Mallinckrodt plc
Mallinckrodt plc (MNKKQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MNKKQ · as of Jun 9, 2026
Key Statistics
Explore Mallinckrodt plc Data
mnkkq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 0.0%
Competitors & Peers
mnkkq competitorsMNKKQ
ACNNF
CANB
CBDNF
CIMVF
ETRGFStock Performance
Full HistoryAbout Mallinckrodt plc
Mallinckrodt plc Headquartered in Dublin, Ireland, Mallinckrodt plc is engaged in the global development, manufacturing, commercialization, and distribution of specialized pharmaceutical products and therapeutic solut…
what is mallinckrodt plc · mnkkq stock overview · mallinckrodt plc company profile · who is mallinckrodt plc ceo · mnkkq OTC · mallinckrodt plc headquarters · mallinckrodt plc business segments
About Stock Overview & Key Data
Mallinckrodt plc (MNKKQ) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jun 17, 2013. As of the latest trading session, MNKKQ stock price is $0.02, with a market capitalization of $0. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Mallinckrodt plc stock is Sell, with an average 12-month price target of $—. In fiscal year 2025, Mallinckrodt plc reported revenue of $1.4B and net income of -$489.5M. For detailed data — including Mallinckrodt plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mallinckrodt plc (MNKKQ) stock price is $0.02. The stock is traded on OTC under the ticker symbol MNKKQ. The 52-week range is $0.02 – $0.02.